Patients undergoing cardiac surgery could develop excessive perioperative bleeding requiring
transfusions of blood products.
Desmopressin (DDAVP), already used for patients with von Willebrand syndrome, could reduce
bleeding and transfusion requirements in these patients when administered ev (0.3 mg/kg) in
20-30 minutes postoperatively.